Posted On: 07/15/2016 1:48:21 PM
Post# of 47078
Pressure BioSciences, Inc. (OTCQB: PBIO) will assist Children’s Medical Research Institute in Sydney, Australia in analyzing approximately 70,000 tumor biopsy samples over the next seven years using PBIO’s pressure cycling technology (PCT) and SCIEX’s SWATH Acquisition. For more information, read here: https://upticknewswire.com/pressure-bioscienc...ith-globa/
Uptick Newswire provided the above as a paid service. It is understood that investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence. We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
Uptick Newswire provided the above as a paid service. It is understood that investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence. We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
(0)
(0)Scroll down for more posts ▼
